...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Promissory Note
2
Jan 30, 2021 05:19PM
2
Jan 30, 2021 05:21PM
2
Jan 31, 2021 10:51AM
4
Jan 31, 2021 01:47PM
4
Jan 31, 2021 02:39PM
2
Jan 31, 2021 07:36PM

..I am showing 53000 shares traded OTC so far today...hummm.

Share
New Message
Please login to post a reply